Login / Register
MS Validated Antibodies - Logo
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
×

Cancer Tissue Gallery E-Cadherin

Path Created with Sketch.
Go to E-Cadherin Normal Tissue GalleryGo back to Product Page
Breast- Absence of E-cadherin staining in a lobular breast cancer.
Breast- Absence of E-cadherin staining in a lobular breast cancer.
Breast- Absence of E-cadherin staining in an invasive lobular breast cancer. Normal breast gland with strong E-cadherin staining serves as an internal staining control.
Breast- Absence of E-cadherin staining in an invasive lobular breast cancer. Normal breast gland with strong E-cadherin staining serves as an internal staining control.
Breast- E-Cadherin negative invasive lobular breast cancer. Normal breast tissue with strong E-Cadherin staining serves as an internal control.
Breast- E-Cadherin negative invasive lobular breast cancer. Normal breast tissue with strong E-Cadherin staining serves as an internal control.
Breast- E-cadherin negative invasive lobular breast cancer. Normal breast tissue with strong E-cadherin staining serves as an internal staining control
Breast- E-cadherin negative invasive lobular breast cancer. Normal breast tissue with strong E-cadherin staining serves as an internal staining control
Breast- Invasive breast cancer of no special type (NST) exhibiting strong E-Cadherin staining of tumor cells.
Breast- Invasive breast cancer of no special type (NST) exhibiting strong E-Cadherin staining of tumor cells.
Breast- Invasive breast cancer of no special type (NST) showing an intense E-Cadherin immunostaining of all tumor cells.
Breast- Invasive breast cancer of no special type (NST) showing an intense E-Cadherin immunostaining of all tumor cells.
Breast- Invasive breast cancer of no special type (NST) with strong E-Cadherin immunostaining of tumor cells.
Breast- Invasive breast cancer of no special type (NST) with strong E-Cadherin immunostaining of tumor cells.
Breast- Strong diffuse E-cadherin positivity in a breast cancer of no special type (NST).
Breast- Strong diffuse E-cadherin positivity in a breast cancer of no special type (NST).
Kidney- Chromophobe renal cell carcinoma with strong membranous E-cadherin immunostaining.
Kidney- Chromophobe renal cell carcinoma with strong membranous E-cadherin immunostaining.
Kidney- E-Cadherin negative clear cell carcinoma.
Kidney- E-Cadherin negative clear cell carcinoma.
Pancreas- Ductal adenocarcinoma with strong E-Cadherin immunostaining of tumor cells.
Pancreas- Ductal adenocarcinoma with strong E-Cadherin immunostaining of tumor cells.
Prostate- Absence of E-cadherin immunostaining in a recurrent prostate cancer showing a discohesive growth pattern
Prostate- Absence of E-cadherin immunostaining in a recurrent prostate cancer showing a discohesive growth pattern
Stomach- Largely reduced E-cadherin staining in a gastric adenocarcinoma (diffuse type)
Stomach- Largely reduced E-cadherin staining in a gastric adenocarcinoma (diffuse type)
Testis- Seminoma with a weak to moderate E-cadherin immunostaining in tumor cells.
Testis- Seminoma with a weak to moderate E-cadherin immunostaining in tumor cells.
Thyroid- Follicular cancer with strong E-Cadherin immunostaining of tumor cells.
Thyroid- Follicular cancer with strong E-Cadherin immunostaining of tumor cells.
Thyroid- Medullary thyroid cancer with strong E-cadherin immunostaining in all tumor cells.
Thyroid- Medullary thyroid cancer with strong E-cadherin immunostaining in all tumor cells.
Urinary Bladder- Complete lack of E-cadherin staining in a urothelial bladder cancer with discohesive growth pattern.
Urinary Bladder- Complete lack of E-cadherin staining in a urothelial bladder cancer with discohesive growth pattern.
Urinary Bladder- Muscle-invasive urothelial carcinoma with discohesive growth pattern and decreased E-cadherin expression.
Urinary Bladder- Muscle-invasive urothelial carcinoma with discohesive growth pattern and decreased E-cadherin expression.
Urinary bladder- Muscle-invasive urothelial carcinoma with strong E-Cadherin immunostaining of tumor cells.
Urinary bladder- Muscle-invasive urothelial carcinoma with strong E-Cadherin immunostaining of tumor cells.
Urinary Bladder- Small cell carcinoma with aberrant pattern of E-cadherin staining. Staining shows perinuclear dots instead of a circumferential membrane staining.
Urinary Bladder- Small cell carcinoma with aberrant pattern of E-cadherin staining. Staining shows perinuclear dots instead of a circumferential membrane staining.
Uterus- Strong E-Cadherin immunostaining in all cells of a serous endometrium carcinoma.
Uterus- Strong E-Cadherin immunostaining in all cells of a serous endometrium carcinoma.
  • Linkedin
  • My Account
  • Search
    ×
  • Cart 0
© 2025 MS Validated Antibodies
  • Imprint
  • Privacy Policy
  • Distributors